1. ?Sopena N, Heras E, Casas I, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study. Am J Infect Control, 2014, 42(1): 38-42.
5. Thompson DA, Makary MA, Dorman T, et al. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg, 2006, 243(4): 547-552.
10. Dulhunty JM, Webb SA, Paterson DL, et al. A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units. Crit Care Resusc, 2010, 12(3): 162-170.
[10]
11. Vanhems P, Bénet T, Voirin N, et al. Early-onset ventilator-associated pneumonia incidence in intensive care units: [ a surveillance-based ] study. BMC Infect Dis, 2011, 11: 236.
[11]
12. Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA, 2009, 301(20): 2120-2128.
[12]
13. Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med, 2011, 184(12): 1409-1417.
[13]
14. 施晓群, 孙景勇, 倪语星, 等. 2011 年中国 C H INET 铜绿假单胞菌耐药性监测. 中国感染与化疗杂志, 2013, 13(3): 218-221.
4. American Thoracic Society Documents, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005, 171(4): 388-416.
[17]
17. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med, 2000, 132(8): 621-630.